Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Non-Laboratory-based Cannabis Testing Market Size & Growth Forecast 2027–2036, By Segments (Technology, Test Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 8196| Published Date: Jul-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Non-Laboratory-based Cannabis Testing Market size was more than USD 74.02 Million in 2026 and is set to grow at 15.08% CAGR between 2027 and 2036, crossing USD 301.54 Million by 2036. The industry revenue for 2027 is estimated at USD 83.68 Million.

Base Year Value (2025)
USD 67.64 Million
CAGR (2026-2035)
14.5%
Forecast Year Value (2035)
USD 261.97 Million
Historical Data Period
2021-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Non-Laboratory-based Cannabis Testing Market Intelligence Snapshot

Regional Market Dynamics

  • North America led in 2026 through its established cannabis industry, evolving regulatory requirements, and growing adoption of rapid testing for safety and quality.
  • Asia Pacific is expected to grow fastest as cannabis interest, regulatory frameworks, quality-control needs, and awareness of contamination risks increase.

Segment Momentum

  • Spectroscopy held a 61.92% market share in 2026 because it enables rapid, real-time analysis without laboratory infrastructure. Portable and handheld systems improve operational efficiency and support decentralized cannabis testing.
  • Potency testing captured 62.02% of the market in 2026 by supporting cannabinoid measurement, product consistency, quality control, and compliance. Rising demand for reliable strength verification continues to drive its adoption.

Market Expansion Drivers

  • Expanding medical cannabis legalization driving demand for rapid non-lab testing solutions
  • Increasing clinical research on cannabis therapeutics boosting testing requirement across healthcare systems
  • Development of portable diagnostic technologies enabling decentralized cannabis quality testing

Leading Market Participants

  • Leading players in the non-laboratory-based cannabis testing market include Agilent Technologies Inc. (USA), Thermo Fisher Scientific Inc. (USA), PerkinElmer Inc. (USA), Shimadzu Corporation (Japan), Bruker Corporation (USA), Purpl Scientific (USA), Orange Photonics Inc. (USA), GemmaCert Ltd. (Israel), MyDx Inc. (USA), tCheck (USA)

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 74.02 Million
  • 2027 Estimated Market Size: USD 83.68 Million
  • Projected Market Size: USD 301.54 Million by 2036
  • Growth Forecast: 15.08% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Spectroscopy (Technology) | Potency Testing (Test Type)
  • Emerging Opportunity Segment: Spectroscopy (Technology) | Potency Testing (Test Type)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Expanding medical cannabis legalization driving demand for rapid non-lab testing solutions

The continued expansion of medical cannabis legalization across multiple jurisdictions is creating greater demand for accessible testing technologies, supporting growth in the non-laboratory-based cannabis testing market. Healthcare providers, cultivators, dispensaries, and regulatory authorities increasingly require rapid testing solutions to verify product quality, potency, and compliance without relying exclusively on centralized laboratory infrastructure. Portable and point-of-use testing methods improve operational efficiency by enabling faster decision-making throughout cultivation, processing, and distribution activities. These capabilities help support product consistency while facilitating timely quality verification within evolving medical cannabis supply chains.

Increasing clinical research on cannabis therapeutics boosting testing requirement across healthcare systems

Growing scientific interest in cannabis-based therapies will drive the non-laboratory-based cannabis testing market growth by increasing the need for efficient analytical tools throughout clinical research and healthcare environments. Researchers require reliable testing methods to assess cannabinoid composition, product consistency, and formulation quality during preclinical investigations and clinical studies. Decentralized testing technologies enable faster sample evaluation while supporting standardized research workflows across hospitals, research institutions, and healthcare facilities. The expansion of evidence-based cannabis therapeutics also encourages more frequent quality assessment to ensure reproducibility and consistency throughout research and medical applications.

Development of portable diagnostic technologies enabling decentralized cannabis quality testing

Advancements in compact analytical devices and portable diagnostic platforms are strengthening the non-laboratory-based cannabis testing market by enabling quality assessment beyond traditional laboratory settings. Modern handheld and field-deployable testing technologies allow users to perform rapid evaluations of cannabinoid content, product authenticity, and quality parameters at cultivation sites, processing facilities, distribution centers, and retail locations. Improved portability, ease of operation, and faster result generation support decentralized quality assurance while reducing dependence on specialized laboratory resources. These innovations also enhance testing accessibility for a broader range of stakeholders involved in cannabis production, distribution, and healthcare applications.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Expanding medical cannabis legalization driving demand for rapid non-lab testing solutions 2% High North America, Europe High Near Term
Increasing clinical research on cannabis therapeutics boosting testing requirement across healthcare systems 1.9% High North America, Asia Pacific High Near Term
Development of portable diagnostic technologies enabling decentralized cannabis quality testing 1.8% High Europe, North America Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
Largest Market Share in 2026

North America (Largest Region)

The non-laboratory-based cannabis testing market was led by North America in 2026, supported by the region's established cannabis industry, expanding regulatory requirements, and growing emphasis on product safety and quality assurance. The presence of mature cannabis markets has encouraged greater adoption of rapid and convenient testing solutions that can support screening closer to cultivation, processing, and distribution environments. Increasing consumer awareness regarding product purity, potency, and contaminants is also encouraging cannabis businesses to strengthen testing practices, while technological advances in portable and on-site testing are improving accessibility and operational efficiency.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is anticipated to register the fastest growth, driven by increasing interest in cannabis-based products, evolving regulatory frameworks, and growing attention to quality control across emerging markets. As governments and industry participants develop clearer approaches to cannabis cultivation, processing, and product safety, demand for accessible testing technologies is expected to increase. Expanding healthcare and agricultural technology capabilities, together with rising awareness of contamination risks and product consistency, should further support adoption of non-laboratory-based testing solutions across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

On-Site Compliance Testing

The U.S. non-laboratory-based cannabis testing market is expanding as producers seek rapid quality verification and operational efficiency. Companies prioritize portable testing technologies that support compliance, process control, and timely production decisions.

Germany 🇩🇪

Analytical Quality Assurance

Germany focuses on non-laboratory-based cannabis testing technologies that enhance product verification while maintaining analytical reliability. Organizations prioritize standardized testing methods, device accuracy, and quality-focused workflows.

Japan 🇯🇵

Precision Screening Tools

Japan emphasizes portable analytical technologies designed for accurate compound screening and research applications. Market participants focus on measurement consistency, compact instrumentation, and dependable analytical performance.

South Korea 🇰🇷

Portable Analytical Solutions

South Korea continues strengthening portable testing capabilities through innovation in compact analytical devices and sensor technologies. Developers prioritize efficient workflows, reliable detection, and user-friendly operation for specialized applications.

France 🇫🇷

Rapid Verification Systems

France increasingly adopts non-laboratory-based cannabis testing technologies that improve operational efficiency and product verification. Organizations emphasize analytical consistency, portable equipment, and streamlined quality assessment processes.

Italy 🇮🇹

Field Testing Efficiency

Italy supports non-laboratory-based cannabis testing through demand for portable analytical solutions that simplify quality verification. Equipment providers prioritize ease of use, dependable results, and efficient testing across controlled environments.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Non-Laboratory-based Cannabis Testing Market Share (%), Technology, 2025

Spectroscopy
Chromatography
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Technology Segment Analysis: Spectroscopy (Largest & Fastest-Growing Segment)

In the non-laboratory-based cannabis testing market, the spectroscopy segment accounted for the largest share of 61.92% in 2026 and is also projected to be the fastest-growing segment. Spectroscopy technologies enable rapid and efficient analysis of cannabis samples by providing real-time insights into composition, quality, and chemical characteristics without requiring traditional laboratory infrastructure. The increasing need for portable testing solutions among cultivators, manufacturers, and regulators is supporting the adoption of spectroscopy-based systems. Furthermore, advancements in handheld and compact analytical devices are improving accessibility and operational efficiency, strengthening the segment’s growth across decentralized testing environments.

Test Type Segment Analysis: Potency Testing (Largest & Fastest-Growing Segment)

The potency testing segment dominated the non-laboratory-based cannabis testing market, capturing the largest share of 62.02% in 2026 and maintaining its position as the fastest-growing segment. Potency testing plays a critical role in determining cannabinoid concentrations and ensuring product consistency, quality control, and compliance with industry requirements. Growing demand for accurate measurement of active cannabis compounds is driving adoption among producers and retailers seeking reliable testing solutions. In addition, the expansion of consumer awareness regarding product strength and quality is encouraging greater emphasis on potency analysis, supporting continued segment development.

Segment Sub-Segment Largest Segment Fastest Growing
Technology Chromatography, Spectroscopy, Others Spectroscopy Spectroscopy
Test Type Potency Testing, Water Testing, Moisture Testing, Others Potency Testing Potency Testing
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the non-laboratory-based cannabis testing market:

  1. Agilent Technologies, Inc. (USA)
  2. Thermo Fisher Scientific, Inc. (USA)
  3. PerkinElmer, Inc. (USA)
  4. Shimadzu Corporation (Japan)
  5. BrUKer Corporation (USA)
  6. Purpl Scientific (USA)
  7. Orange Photonics, Inc. (USA)
  8. GemmaCert Ltd. (Israel)
  9. MyDx, Inc. (USA)
  10. tCheck (USA)

The non-laboratory-based cannabis testing market is moving toward a competitive environment where ease of use, analytical reliability, and rapid decision-making carry greater strategic importance than simply expanding product availability. Participants are refining portable and user-friendly testing solutions that can support cultivators, processors, distributors, and regulatory stakeholders requiring timely quality verification outside traditional laboratory settings. As expectations for testing accuracy continue to rise, investment is shifting toward technologies that improve consistency while reducing operational complexity for end users. Regulatory alignment, validation standards, and the ability to integrate testing workflows into routine operational practices are creating meaningful competitive distinctions, rewarding suppliers that combine dependable performance with practical deployment across a wide range of field applications.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Non-Laboratory-based Cannabis Testing Market — Custom Segments

Segment Sub-Segment
No segment data available.

Non-Laboratory-based Cannabis Testing Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of non-laboratory-based cannabis testing?

The market size of the non-laboratory-based cannabis testing is estimated at USD 83.68 Million in 2027.

What is the forecasted size of the non-laboratory-based cannabis testing industry?

Non-Laboratory-based Cannabis Testing Market size was more than USD 74.02 Million in 2026 and is set to grow at 15.08% CAGR between 2027 and 2036, crossing USD 301.54 Million by 2036.

How is medical cannabis legalization influencing demand for non-laboratory cannabis testing?

Expanding medical cannabis legalization is increasing demand for portable testing solutions that enable rapid quality, potency, and compliance verification throughout cultivation, processing, distribution, and healthcare workflows.

What role do portable diagnostic technologies play in the non-laboratory-based cannabis testing market?

Handheld and field-deployable testing devices enable decentralized quality assessment with faster results, improving accessibility, operational efficiency, and product verification while reducing dependence on centralized laboratory infrastructure.

Why is spectroscopy the leading technology in the non-laboratory-based cannabis testing market?

Spectroscopy held a 61.92% market share in 2026 because it enables rapid, real-time analysis without laboratory infrastructure. Portable and handheld systems improve operational efficiency and support decentralized cannabis testing.

Why is potency testing gaining strong adoption in the non-laboratory-based cannabis testing market?

Potency testing captured 62.02% of the market in 2026 by supporting cannabinoid measurement, product consistency, quality control, and compliance. Rising demand for reliable strength verification continues to drive its adoption.

What keeps North America ahead in non-laboratory-based cannabis testing?

North America led in 2026 through its established cannabis industry, evolving regulatory requirements, and growing adoption of rapid testing for safety and quality.

How is Asia Pacific creating momentum for non-laboratory-based cannabis testing?

Asia Pacific is expected to grow fastest as cannabis interest, regulatory frameworks, quality-control needs, and awareness of contamination risks increase.

Which companies dominate the non-laboratory-based cannabis testing landscape?

Leading players in the non-laboratory-based cannabis testing market include Agilent Technologies Inc. (USA), Thermo Fisher Scientific Inc. (USA), PerkinElmer Inc. (USA), Shimadzu Corporation (Japan), Bruker Corporation (USA), Purpl Scientific (USA), Orange Photonics Inc. (USA), GemmaCert Ltd. (Israel), MyDx Inc. (USA), tCheck (USA)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →